Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilars: what clinicians should know.
Weise M, Bielsky MC, De Smet K, Ehmann F, Ekman N, Giezen TJ, Gravanis I, Heim HK, Heinonen E, Ho K, Moreau A, Narayanan G, Kruse NA, Reichmann G, Thorpe R, van Aerts L, Vleminckx C, Wadhwa M, Schneider CK. Weise M, et al. Blood. 2012 Dec 20;120(26):5111-7. doi: 10.1182/blood-2012-04-425744. Epub 2012 Oct 23. Blood. 2012. PMID: 23093622 Free article. Review.
Taking immunogenicity assessment of therapeutic proteins to the next level.
Büttel IC, Chamberlain P, Chowers Y, Ehmann F, Greinacher A, Jefferis R, Kramer D, Kropshofer H, Lloyd P, Lubiniecki A, Krause R, Mire-Sluis A, Platts-Mills T, Ragheb JA, Reipert BM, Schellekens H, Seitz R, Stas P, Subramanyam M, Thorpe R, Trouvin JH, Weise M, Windisch J, Schneider CK. Büttel IC, et al. Among authors: weise m. Biologicals. 2011 Mar;39(2):100-9. doi: 10.1016/j.biologicals.2011.01.006. Epub 2011 Feb 24. Biologicals. 2011. PMID: 21353596
Biosimilars-why terminology matters.
Weise M, Bielsky MC, De Smet K, Ehmann F, Ekman N, Narayanan G, Heim HK, Heinonen E, Ho K, Thorpe R, Vleminckx C, Wadhwa M, Schneider CK. Weise M, et al. Nat Biotechnol. 2011 Aug 5;29(8):690-3. doi: 10.1038/nbt.1936. Nat Biotechnol. 2011. PMID: 21822237 No abstract available.
In support of the European Union biosimilar framework.
Schneider CK, Borg JJ, Ehmann F, Ekman N, Heinonen E, Ho K, Hoefnagel MH, van der Plas RM, Ruiz S, van der Stappen AJ, Thorpe R, Tiitso K, Tsiftsoglou AS, Vleminckx C, Waxenecker G, Welin M, Weise M, Trouvin JH; Working Party on Similar Biological (Biosimilar) Medicinal Products (BMWP); Biologicals Working Party (BWP) of the Committee for Medicinal Products for Human Use (CHMP). Schneider CK, et al. Among authors: weise m. Nat Biotechnol. 2012 Aug;30(8):745-8; author reply 748-9. doi: 10.1038/nbt.2322. Nat Biotechnol. 2012. PMID: 22871707 No abstract available.
Setting the stage for biosimilar monoclonal antibodies.
Schneider CK, Vleminckx C, Gravanis I, Ehmann F, Trouvin JH, Weise M, Thirstrup S. Schneider CK, et al. Among authors: weise m. Nat Biotechnol. 2012 Dec;30(12):1179-85. doi: 10.1038/nbt.2447. Nat Biotechnol. 2012. PMID: 23222783 No abstract available.
Biosimilars: the science of extrapolation.
Weise M, Kurki P, Wolff-Holz E, Bielsky MC, Schneider CK. Weise M, et al. Blood. 2014 Nov 20;124(22):3191-6. doi: 10.1182/blood-2014-06-583617. Epub 2014 Oct 8. Blood. 2014. PMID: 25298038 Free article.
[Regulatory aspects of biosimilars. Myths and facts].
Schneider CK, Weise M. Schneider CK, et al. Among authors: weise m. Z Rheumatol. 2015 Oct;74(8):695-700. doi: 10.1007/s00393-014-1489-6. Z Rheumatol. 2015. PMID: 26385104 German.
Biosimilars: Here and Now.
Lemery SJ, Esteva FJ, Weise M. Lemery SJ, et al. Among authors: weise m. Am Soc Clin Oncol Educ Book. 2016;35:e151-7. doi: 10.1200/EDBK_155954. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249717 Free article.
Interchangeability of Biosimilars: A European Perspective.
Kurki P, van Aerts L, Wolff-Holz E, Giezen T, Skibeli V, Weise M. Kurki P, et al. Among authors: weise m. BioDrugs. 2017 Apr;31(2):83-91. doi: 10.1007/s40259-017-0210-0. BioDrugs. 2017. PMID: 28120313
203 results